An omnibus test for detection of subgroup treatment effects via data partitioning
- 1 December 2022
- journal article
- research article
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 16 (4) , 2266-2278
Abstract
Late-stage clinical trials have been conducted primarily to establish the efficacy of a new treatment in an intended population. A corollary of population heterogeneity in clinical trials is that a treatment might be effective for one or more subgroups, rather than for the whole population of interest. As an example, the phase III clinical trial of panitumumab in metastatic colorectal cancer patients failed to demonstrate its efficacy in the overall population, but a subgroup associated with tumor KRAS status was found to be promising (Peeters et al. (Am. J. Clin. Oncol. 28 (2010) 4706–4713)). As we search for such subgroups via data partitioning based on a large number of biomarkers, we need to guard against inflated type I error rates due to multiple testing. Commonly-used multiplicity adjustments tend to lose power for the detection of subgroup treatment effects. We develop an effective omnibus test to detect the existence of, at least, one subgroup treatment effect, allowing a large number of possible subgroups to be considered and possibly censored outcomes. Applied to the panitumumab trial data, the proposed test would confirm a significant subgroup treatment effect. Empirical studies also show that the proposed test is applicable to a variety of outcome variables and maintains robust statistical power.Keywords
This publication has 28 references indexed in Scilit:
- Inference for Subgroup Analysis With a Structured Logistic-Normal Mixture ModelJournal of the American Statistical Association, 2015
- Censored rank independence screening for high-dimensional survival dataBiometrika, 2014
- Fast Censored Linear RegressionScandinavian Journal of Statistics, 2013
- On the robustness of the adaptive lasso to model misspecificationBiometrika, 2012
- The Problem of Subgroup Analyses: An Example from a Trial on Ruptured Intracranial AneurysmsAmerican Journal of Neuroradiology, 2011
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2010
- Improving the precision of classification treesThe Annals of Applied Statistics, 2009
- The Adaptive Lasso and Its Oracle PropertiesJournal of the American Statistical Association, 2006
- Estimating Regression Parameters Using Linear Rank Tests for Censored DataThe Annals of Statistics, 1990
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965